Cargando…
Identification of SARS-CoV-2–induced pathways reveals drug repurposing strategies
The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the rapid development of new therapies against coronavirus disease 2019 (COVID-19) infection. Here, we present the identification of 200 approved drugs, appropriate for repurposing against COVID-19. We c...
Autores principales: | Han, Namshik, Hwang, Woochang, Tzelepis, Konstantinos, Schmerer, Patrick, Yankova, Eliza, MacMahon, Méabh, Lei, Winnie, M. Katritsis, Nicholas, Liu, Anika, Felgenhauer, Ulrike, Schuldt, Alison, Harris, Rebecca, Chapman, Kathryn, McCaughan, Frank, Weber, Friedemann, Kouzarides, Tony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245040/ https://www.ncbi.nlm.nih.gov/pubmed/34193418 http://dx.doi.org/10.1126/sciadv.abh3032 |
Ejemplares similares
-
Current and prospective computational approaches and challenges for developing COVID-19 vaccines
por: Hwang, Woochang, et al.
Publicado: (2021) -
dialogi: Utilising NLP With Chemical and Disease Similarities to Drive the Identification of Drug-Induced Liver Injury Literature
por: Katritsis, Nicholas M., et al.
Publicado: (2022) -
DILI(
C
): An AI-Based Classifier to Search for Drug-Induced Liver Injury Literature
por: Rathee, Sanjay, et al.
Publicado: (2022) -
Identification of potential pan-coronavirus therapies using a computational drug repurposing platform
por: Hwang, Woochang, et al.
Publicado: (2022) -
DDX3X RNA helicase affects breast cancer cell cycle progression by regulating expression of KLF4
por: Cannizzaro, Ester, et al.
Publicado: (2018)